Your browser doesn't support javascript.
loading
Reestablishment of active immunity against HBV graft reinfection after liver transplantation for HBV-related end stage liver disease.
Lu, Shi-Chun; Jiang, Tao; Lai, Wei; Liu, Yuan; Zhang, Jing; Zeng, Dao-Bing; Li, Chuan-Yun; Wang, Meng-Long; Lin, Dong-Dong; Zhu, Yue; Li, You-Ping; Li, Ning.
Affiliation
  • Lu SC; Department of Hepatobiliary Surgery and Liver Transplantation Program, Beijing You-An Hospital, Capital Medical University, Beijing 100069, China ; Institute & Hospital of Hepatobiliary Surgery, Key Laboratory of Digital Hepatobiliary Surgery of Chinese PLA, Chinese PLA Medical School, Chinese P
  • Jiang T; Department of Hepatobiliary Surgery and Liver Transplantation Program, Beijing You-An Hospital, Capital Medical University, Beijing 100069, China.
  • Lai W; Department of General Surgery, Chengdu First People's Hospital, Sichuan 610041, China.
  • Liu Y; Department of Hepatobiliary Surgery and Liver Transplantation Program, Beijing You-An Hospital, Capital Medical University, Beijing 100069, China.
  • Zhang J; Department of Hepatobiliary Surgery and Liver Transplantation Program, Beijing You-An Hospital, Capital Medical University, Beijing 100069, China.
  • Zeng DB; Department of Hepatobiliary Surgery and Liver Transplantation Program, Beijing You-An Hospital, Capital Medical University, Beijing 100069, China.
  • Li CY; Department of Hepatobiliary Surgery and Liver Transplantation Program, Beijing You-An Hospital, Capital Medical University, Beijing 100069, China.
  • Wang ML; Department of Hepatobiliary Surgery and Liver Transplantation Program, Beijing You-An Hospital, Capital Medical University, Beijing 100069, China.
  • Lin DD; Department of Hepatobiliary Surgery and Liver Transplantation Program, Beijing You-An Hospital, Capital Medical University, Beijing 100069, China.
  • Zhu Y; Department of Hepatobiliary Surgery and Liver Transplantation Program, Beijing You-An Hospital, Capital Medical University, Beijing 100069, China.
  • Li YP; Key Laboratory of Transplant Engineering and Immunology of Health Ministry, West China Hospital, Sichuan University, Chengdu, Sichuan 610044, China.
  • Li N; Department of Hepatobiliary Surgery and Liver Transplantation Program, Beijing You-An Hospital, Capital Medical University, Beijing 100069, China.
J Immunol Res ; 2014: 764234, 2014.
Article in En | MEDLINE | ID: mdl-25759834
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Hepatitis B virus / Liver Transplantation / Hepatitis B Vaccines / End Stage Liver Disease / Hepatitis B / Hepatitis B Antigens Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Immunol Res Year: 2014 Document type: Article Country of publication: Egipto
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Hepatitis B virus / Liver Transplantation / Hepatitis B Vaccines / End Stage Liver Disease / Hepatitis B / Hepatitis B Antigens Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Immunol Res Year: 2014 Document type: Article Country of publication: Egipto